Capital Analysts »

Diamedica Therapeutics shares owned by Capital Analysts

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Capital Analysts

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.0k 1.1k 7.62

More positions owned by Capital Analysts

Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Core Msci Emkt (IEMG)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Fidelity Covington Trust Enhanced Mid (FMDE)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Spdr Series Trust State Street Spd (SPIB)
Franklin Templeton Etf Tr Intl Cor Div Til (DIVI)
Spdr Series Trust State Street Spd (SPHY)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Blackrock Etf Trust Ishares Us Equit (DYNF)

View all positions for Capital Analysts

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Northern Trust
Advisor Group Holdings
LPL Financial
Goldman Sachs Group
Bank of New York Mellon
Nuveen

View all funds holding Diamedica Therapeutics